Dr. Lawrence is an American biogerontologist with a Jurisprudence Degree (UCLA-Law), an MS in Psychology, and a Ph.D. in Nutritional Science. For three decades, his focus has been human longevity research and interventions for optimal life and healthspan.

Dr. Lawrence has been affiliated with the St. Petersburg Institute of Bioregulation and Gerontology (Russia) since 2015. He is the administrator of two Russian and American longevity clinical studies: Telomerase activation and DNA/Methylation modification. These studies use Peptide Bioregulators, developed by Prof. Vladimir Khavinson, Director of the St. Petersburg Institute, for human organ regeneration, mortality reduction, and reversing human biological aging.

Based on positive clinical study results, Dr. Lawrence developed the Peptide Longevity Program, which reverses human biological aging biomarkers, regenerating human organs and systems and potentially significantly reducing human mortality. His presentation today will include the scientific data and evidence supporting the Peptide Longevity Program.